Long-term Prostate Cancer Mortality Outcomes

María Natalia Gandur Quiroga shared on X about an article titled “Long-term Prostate Cancer–specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer” published on European Urology.

Authors: Annika Herlemann, Janet E. Cowan, Samuel L. Washington 3rd, Anthony C. Wong, Jeanette M. Broering, Peter R. Carroll, Matthew R. Cooperberg.

“Long-term Prostate Cancer Mortality Outcomes: Surgery vs. Radiation, Hormonal Therapy, or Monitoring.

Study Overview:

Participants: 11,864 men with localized prostate cancer

Results:

Radical Prostatectomy (RP): Lowest mortality

Comparative Treatments:

Brachytherapy (BT): HR 1.57

External Beam Radiation Therapy (EBRT): HR 1.55

Primary Androgen Deprivation Therapy (PADT): HR 2.36

Active Surveillance/Watchful Waiting (AS/WW): HR 1.76

Next Steps:

Ongoing trials: Awaiting long-term confirmation.

Full article.”

Source: María Natalia Gandur Quiroga/X

Maria Natalia Gandur Quiroga is a Medical Oncologist and Chief of the Division of Genitourinary Medical Oncology at the Ángel H. Roffo Oncology Institute in Buenos Aires, Argentina. She is a Professor of Medicine at the University of Buenos Aires at the Oncologists Post Graduates Studies. Her research focuses on clinical trials with aims to improve the treatment of patients with urologic tumors.

She is an active member of the European Association for Cancer Research, Argentinian Medical Association and American Society of Clinical Oncology.